Australians facing crushing waitlists for attention deficit hyperactivity disorder assessments will soon turn to local doctors, as state governments progressively reform prescribing rules to empower general practitioners.
The Guardian Australia reported that several jurisdictions have begun overhauling clinical frameworks to grant GPs a central role in both diagnosing ADHD and managing stimulant medications. The shift represents the most significant shake-up in neurodevelopmental healthcare in decades, targeting a system that advocates have long argued is broken by exorbitant private fees and acute specialist shortages.
Dismantling the specialist bottleneck
Under Australia's longstanding regulatory framework, individuals seeking an ADHD diagnosis were required to obtain a referral from their primary care physician before seeing a private psychiatrist or paediatrician. While designed as a safeguard for Schedule 8 stimulant prescriptions, this structure created severe structural bottlenecks.
Patients routinely confront wait times spanning between 12 and 24 months, while initial specialist assessments frequently incur out-of-pocket costs exceeding $1,500. The burden falls disproportionately on regional and lower-income Australians, where psychiatric services are scarce or entirely absent. Rising community awareness and a surge in adults seeking retrospective diagnoses have further overwhelmed private clinics, leaving thousands languishing without clinical support.
Patchwork regulatory shifts across jurisdictions
In response to mounting public pressure, state and territory authorities have initiated changes to allow accredited GPs to either initiate treatment or manage ongoing medication regimes under shared-care models.
As highlighted by The Guardian Australia, regulatory pathways differ markedly across state borders. Some jurisdictions are expanding pilot programmes that permit doctors with specialised neurodevelopmental training to diagnose uncomplicated adult cases directly. Others are loosening bureaucratic restrictions on Schedule 8 permits, removing the mandatory requirement for annual specialist reviews once a patient is clinically stable.
Advocacy organisations have broadly welcomed the measures, noting that family physicians often possess a more holistic understanding of a patient's longitudinal medical and social history than a consulting specialist seen once a year.
Balancing accessibility with clinical safeguards
Despite broad support for reducing patient friction, peak medical bodies maintain that expanded scope of practice must be matched with rigorous training and systemic funding.
Professional colleges, including the Royal Australian College of General Practitioners (RACGP), have emphasised that thorough ADHD assessments demand comprehensive consultations spanning several hours. Under current Medicare Benefits Schedule (MBS) rebates, standard short consultations remain poorly suited to complex psychiatric evaluations.
Moreover, clinicians stress the ongoing need to differentiate ADHD from comorbid conditions such as anxiety, depression, and trauma. While empowering trusted family doctors will alleviate severe strain on the public hospital system, medical leaders caution that primary care must be properly resourced to ensure diagnostic integrity is not compromised in the pursuit of access.
